The CTLA-4 X OX40 Bispecific Antibody ATOR-1015 Induces Anti-Tumor Effects Through Tumor-Directed Immune Activation
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/s40425-019-0570-8
Full Text
Open PDFAbstract
Available in full text
Date
April 11, 2019
Authors
Publisher
BMJ